TheProfitWatch

MIRA - MIRA Pharmaceuticals, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.32 0.91 (68.94%) -0.03 (-1.33%) 0.0 (0.0%) 0.0 (0.0%) 0.01 (0.73%) -0.01 (-0.75%) 0.9 (67.67%) 0.9 (67.67%)

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.09
Diluted EPS:
-0.09
Basic P/E:
-24.7778
Diluted P/E:
-24.7778
RSI(14) 1m:
26.82
VWAP:
2.25
RVol:

Events

Period Kind Movement Occurred At
1m Price increase 1m 1.97 +0.03 (+1.55%) Oct 15 16:14

Related News